Combining immunotherapy with radiation for the treatment of glioblastoma (Q38422623)

3 September 2017

1 reference

title

Combining immunotherapy with radiation for the treatment of glioblastoma (English)

1 reference

3 September 2017

1 reference

3

Michael Lim

1 reference

3 September 2017

Kevin K H Chow

1

1 reference

3 September 2017

Wendy Hara

series ordinal

2

1 reference

3 September 2017

Gordon Li

series ordinal

4

1 reference

3 September 2017

publication date

17 April 2015

1 reference

Journal of Neuro-Oncology

3 September 2017

published in

1 reference

3 September 2017

volume

123

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

459-464

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Cellular immunotherapy for high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

The future of glioblastoma therapy: synergism of standard of care and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Glioblastoma-derived mechanisms of systemic immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

T cells redirected to EphA2 for the immunotherapy of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Survival after stereotactic biopsy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

The effect of irradiation on expression of HLA class I antigens in human brain tumors in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Radiation therapy to convert the tumor into an in situ vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Combining radiotherapy and cancer immunotherapy: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-015-1762-9

Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors

21 January 2018

1 reference

12 December 2020

Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma

1 reference

12 December 2020

Current vaccine trials in glioblastoma: a review

1 reference

12 December 2020

Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis

1 reference

12 December 2020

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

12 December 2020

Changes in T-cell subsets after radiation therapy

1 reference

12 December 2020

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

1 reference

12 December 2020

The abscopal effect: demonstration in lymphomatous involvement of kidneys

1 reference

12 December 2020

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

1 reference

12 December 2020

10.1007/S11060-015-1762-9

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1036831088

0 references

1 reference